BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 59937)

  • 1. Alpha 2-macroglobulin and antithrombin-heparin cofactor: modulators of hemostatic and inflammatory reactions. Alpha 2-macroglobulin.
    Harpel PC; Rosenberg RD
    Prog Hemost Thromb; 1976; 3():145-89. PubMed ID: 59937
    [No Abstract]   [Full Text] [Related]  

  • 2. [Relationship between antiplasmin capacity and concentration of alpha 2-plasmin inhibitor, alpha 2-macroglobulin, alpha 1-antitrypsin, antithrombin III or C1-inactivator in plasma of patients with transient ischemic attacks (author's transl)].
    Matsuda T; Seki T; Miura R; Ogawara M; Yokouchi M; Yamanouchi H
    Rinsho Byori; 1980 Mar; 28(3):261-4. PubMed ID: 6154815
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo catabolism of alpha 1-proteinase inhibitor-trypsin, antithrombin III-thrombin and alpha 2-macroglobulin-methylamine.
    Fuchs HE; Shifman MA; Pizzo SV
    Biochim Biophys Acta; 1982 May; 716(2):151-7. PubMed ID: 6178438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes of antithrombin III, alpha2-macroglobulin, alpha1-antitrypsin, C1-inhibitor and alpha2-plasmin inhibitor in arteriosclerotic diseases and diabetes mellitus (author's transl)].
    Matsuda T
    Rinsho Ketsueki; 1978 Jul; 19(7):947-54. PubMed ID: 81330
    [No Abstract]   [Full Text] [Related]  

  • 5. [Howie's antithrombin activity and thrombin inhibitors in the nephrotic syndrome].
    Campo G; Modena N; Gallo A; Ciaffoni S
    Quad Sclavo Diagn; 1985 Mar; 21(1):106-16. PubMed ID: 2414802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human plasma proteinase inhibitors.
    Travis J; Salvesen GS
    Annu Rev Biochem; 1983; 52():655-709. PubMed ID: 6193754
    [No Abstract]   [Full Text] [Related]  

  • 7. [A study of antithrombin systems during heparin therapy].
    Boneu B; Immaculato F; Sie P; Caranobe C; Chamontin B; Guittard J
    Nouv Presse Med; 1982 Oct; 11(41):3043-6. PubMed ID: 6183640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in nephrotic syndrome.
    Boneu B; Bouissou F; Abbal M; Sie P; Caranobe C; Barthe P
    Thromb Haemost; 1981 Oct; 46(3):623-5. PubMed ID: 6171906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease inhibitor and gastric cancer.
    Tsumoto S; Oyabu H; Kageyama T
    Bull Osaka Med Sch; 1983 Jul; 29(1):18-26. PubMed ID: 6204707
    [No Abstract]   [Full Text] [Related]  

  • 10. [Physiological anticoagulants. Current data on the composition, function and clinical value].
    Barkagan ZS; Bishevskii KM
    Lab Delo; 1978; (10):579-87. PubMed ID: 81906
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunologic studies on platelet antiproteases.
    Nalli G; Majolino I; Fornasari PM; Cattaneo G; Malamani GD; Almasio P; Piovella F; Ascari E
    Haematologica; 1978 Apr; 63(2):156-62. PubMed ID: 79518
    [No Abstract]   [Full Text] [Related]  

  • 12. Familial thrombosis due to antithrombin III deficiency in a Greek family.
    Stathakis NE; Papayannis AG; Antonopoulos M; Gardikas C
    Acta Haematol; 1977; 57(1):47-54. PubMed ID: 65891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha 1-antitrypsin, alpha 1-antichymotrypsin and alpha 2-macroglobulin in human liver fluke (opisthorchiasis).
    Changbumrung S; Migasena P; Supawan V; Buavatana T; Migasena S
    Tropenmed Parasitol; 1982 Sep; 33(3):195-7. PubMed ID: 6182657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proteinase inhibitors and fibrinogen split products in patients with malignant diseases (author's transl)].
    Schwarz HP; Aiginger P; Kuzmits R
    Acta Med Austriaca; 1981; 8(1):22-5. PubMed ID: 6165218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The changes of natural clotting and fibrinolytic inhibitors in collagen and collagen like diseases (author's transl)].
    Oguri T; Hosoi A
    Rinsho Ketsueki; 1978 Jul; 19(7):940-6. PubMed ID: 81329
    [No Abstract]   [Full Text] [Related]  

  • 16. [Protease inhibitors].
    Lambin P
    Rev Fr Transfus Immunohematol; 1980 May; 23(2):147-83. PubMed ID: 6161406
    [No Abstract]   [Full Text] [Related]  

  • 17. High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein.
    Olson ST; Sheffer R; Francis AM
    Biochemistry; 1993 Nov; 32(45):12136-47. PubMed ID: 7692967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does heparin modify protease-antiprotease balance in acute experimental pancreatitis in rats.
    Gabryelewicz A; Kosidlo S; Prokopowicz J; Podkowicz K
    Hepatogastroenterology; 1986 Apr; 33(2):79-82. PubMed ID: 2424815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antithrombin III, alpha 2-macroglobulin, alpha 1-antitrypsin and plasminogen in childhood diabetes].
    Kotschy M; Wasikowa R; Iwanicka Z; Ciosek W
    Pol Tyg Lek; 1984 Apr; 39(18):611-3. PubMed ID: 6085653
    [No Abstract]   [Full Text] [Related]  

  • 20. Respective roles of antithrombin III and alpha 2 macroglobulin in thrombin inactivation.
    Fischer AM; Tapon-Bretaudiere J; Bros A; Josso F
    Thromb Haemost; 1981 Feb; 45(1):51-4. PubMed ID: 6166063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.